Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) EPS (Weighted Average and Diluted): 2024-2025

Historic EPS (Weighted Average and Diluted) for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to -$0.85.

  • Kura Oncology's EPS (Weighted Average and Diluted) fell 34.92% to -$0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.48, marking a year-over-year change of. This contributed to the annual value of -$2.02 for FY2024, which is 2.88% up from last year.
  • Latest data reveals that Kura Oncology reported EPS (Weighted Average and Diluted) of -$0.85 as of Q3 2025, which was down 13.33% from -$0.75 recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's EPS (Weighted Average and Diluted) ranged from a high of -$0.22 in Q4 2024 and a low of -$0.85 during Q3 2025.
  • Over the past 2 years, Kura Oncology's median EPS (Weighted Average and Diluted) value was -$0.63 (recorded in 2024), while the average stood at -$0.61.
  • Data for Kura Oncology's EPS (Weighted Average and Diluted) shows a maximum YoY slumped of 34.92% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Kura Oncology's EPS (Weighted Average and Diluted) stood at -$0.22 in 2024, then crashed by 34.92% to -$0.85 in 2025.
  • Its last three reported values are -$0.85 in Q3 2025, -$0.75 for Q2 2025, and -$0.66 during Q1 2025.